SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-08-030524
Filing Date
2008-02-14
Accepted
2008-02-14 10:43:13
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G AMENDMENT NO. 3 dsc13ga.htm SC 13G/A 50357
  Complete submission text file 0001193125-08-030524.txt   52277
Mailing Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121
Business Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Subject) CIK: 0000881464 (see all company filings)

IRS No.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-42168 | Film No.: 08609505
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1200 17TH ST STE 1600 DENVER CO 80202
Business Address 1200 17TH ST STE 1600 DENVER CO 80202 3034545600
MARSICO CAPITAL MANAGEMENT LLC (Filed by) CIK: 0001055966 (see all company filings)

IRS No.: 841434992 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A